Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Levinson, US
Barrie Levinson, Portland, OR US
| Patent application number | Description | Published |
|---|---|---|
| 20090254387 | TECHNIQUE FOR PERFORMING TRIPLE BOTTOM-LINE ASSESSMENTS - Embodiments of a computer system for determining a social responsibility metric are described. During operation, the computer system aggregates information associated with financial transactions of a user to determine the social responsibility metric. Note that the financial transactions may be included in a data structure associated with financial software, and the data structure may be stored in a computer-readable medium. Next, the computer system may provide the social responsibility metric to the user. | 10-08-2009 |
Barry Levinson, Highland Park, NJ US
| Patent application number | Description | Published |
|---|---|---|
| 20090030079 | USES OF TRIENTINE AND PENICILLAMINE AS COUNTERMEASURES TO METAL CONTAMINATION - Methods are provided for the alleviation, prevention and treatment of negative effects of overexposure to metal contaminants. Subjects exposed to a metal contaminant can be treated using trientine and/or penicillamine or salts, esters, solvates thereof. In addition, communities can protect its members by securing sufficient quantities of such countermeasures. | 01-29-2009 |
Benjamin Levinson, Montgomery, NJ US
| Patent application number | Description | Published |
|---|---|---|
| 20100280237 | PREPARATION OF METAL MESOPORPHYRIN COMPOUNDS - A method of preparing metal mesoporphyrin halide compounds is described. The metal mesoporphyrin halide compound may be formed by forming a novel mesoporphyrin IX intermediate compound and then converting the mesoporphyrin IX intermediate to the metal mesoporphyrin halide through metal insertion. The novel intermediate compound may be formed by a catalytic hydrogenation of hemin in acid and subsequent recovery. | 11-04-2010 |
David Jonathan Levinson, Acworth, GA US
| Patent application number | Description | Published |
|---|---|---|
| 20120036474 | Table Management - The different illustrative embodiments provide a method, computer system, and computer program product to manage a display of objects. A processor unit displays a graphical control configured to receive a user input of a value to control the display of a set of objects relative to a group of properties for the set of objects in a table. A processor unit changes the display of the set of objects to a ratio in a plurality of ratios in the table for the set of objects relative to the group of properties for the set of objects in the table based on the value. | 02-09-2012 |
Dennis J. Levinson, Glenview, IL US
| Patent application number | Description | Published |
|---|---|---|
| 20100039612 | Microbial cellulose contact lens - The present invention provides a contact lens from | 02-18-2010 |
Douglas Levinson, Sherborn, MA US
| Patent application number | Description | Published |
|---|---|---|
| 20090023589 | METHODS FOR IDENTIFYING CONDITIONS AFFECTING A CELL STATE - The present invention is directed to methods for identifying agents which affect cell state. The instant invention provides rapid and efficient methods for identifying agents which affect cell state. Methods are directed toward the screening of complex combinations of agents for their ability to affect cell state. In one embodiment, cells are incubated under suitable conditions and subjected to different agents. After an appropriate amount of time, the cells are assayed to determine what, if any, characteristics they possess. Cell characteristics can be organized in a manner such that different and novel cell states can be identified. | 01-22-2009 |
Douglas Adam Levinson, Sherborn, MA US
| Patent application number | Description | Published |
|---|---|---|
| 20090041752 | Compositions and methods for the treatment and diagnosis of immune disorders - The present invention relates to methods and compositions for the treatment and diagnosis of immune disorders, especially T helper lymphocyte-related disorders, and also for the treatment of mast cell-related processes and disorders, ischemic disorders and injuries, including ischemic renal disorders and injuries. For example, genes which are differentially expressed within and among T helper (TH) cells and TH cell subpopulations, which include, but are not limited to TH0, TH1 and TH2 cell subpopulations are identified. Genes are also identified via the ability of their gene products to interact with gene products involved in the differentiation, maintenance and effector function of such TH cells and TH cell subpopulations. The genes identified can be used diagnostically or as targets for therapeutic intervention. In this regard, the present invention provides methods for the identification and therapeutic use of compounds as treatments of immune disorders, especially TH cell subpopulation-related disorders. Additionally, methods are provided for the diagnostic evaluation and prognosis of TH cell subpopulation-related disorders, for the identification of subjects exhibiting a predisposition to such conditions, for monitoring patients undergoing clinical evaluation for the treatment of such disorders, and for monitoring the efficacy of compounds used in clinical trials. Methods are also provided for the treatment of symptoms associated with mast cell-related processes or disorders and ischemic disorders and injuries using the genes, gene products and antibodies of the invention. | 02-12-2009 |
| 20110123548 | COMPOSITIONS AND METHODS FOR THE TREATMENT AND DIAGNOSIS OF IMMUNE DISORDERS - The present invention relates to methods and compositions for the treatment and diagnosis of immune disorders, especially T helper lymphocyte-related disorders, and also for the treatment of mast cell-related processes and disorders, ischemic disorders and injuries, including ischemic renal disorders and injuries. For example, genes which are differentially expressed within and among T helper (TH) cells and TH cell subpopulations, which include, but are not limited to TH0, TH1 and TH2 cell subpopulations are identified. Genes are also identified via the ability of their gene products to interact with gene products involved in the differentiation, maintenance and effector function of such TH cells and TH cell subpopulations. The genes identified can be used diagnostically or as targets for therapeutic intervention. In this regard, the present invention provides methods for the identification and therapeutic use of compounds as treatments of immune disorders, especially TH cell subpopulation-related disorders. Additionally, methods are provided for the diagnostic evaluation and prognosis of TH cell subpopulation-related disorders, for the identification of subjects exhibiting a predisposition to such conditions, for monitoring patients undergoing clinical evaluation for the treatment of such disorders, and for monitoring the efficacy of compounds used in clinical trials. Methods are also provided for the treatment of symptoms associated with mast cell-related processes or disorders and ischemic disorders and injuries using the genes, gene products and antibodies of the invention. | 05-26-2011 |
Eric D. Levinson, Woodbury, MN US
| Patent application number | Description | Published |
|---|---|---|
| 20100103808 | Optical media manufactured with low-grade materials - This disclosure describes optical media that is compatible with conventional DVD drives. Unlike conventional DVDs, however, the described media uses a lower cost, lower quality material for one of the substrates. In particular, a so-called “dummy” substrate may comprise a non-optical grade polymeric material. In some cases, the dummy substrate may include post-consumer recycled materials, such as recycled polycarbonate. In other cases, dummy substrate may comprise a low cost non-optical grade polycarbonate, such as an industrial grade polycarbonate. In still other cases, the dummy substrate may comprise a polycarbonate blend, or other non-polycarbonate materials. | 04-29-2010 |
| 20100214905 | Stacking techniques for thin optical data storage media - This disclosure relates to thin optical storage media that may be compliant with conventional DVD drives. Unlike conventional DVDs, however, the described media generally has a thickness profile less than 1.2 mm. The media may further include one or more protrusions protruding from a major surface of the media which define a thickness of approximately 1.2 mm within the clamping area of the media. In some embodiments, the media may further include one or more recesses recessed into a major surface within the clamping area of the media. Two or more optical storage media may be packaged by stacking the media in a configuration that defines an overall stacked thickness that is less than 1.2 mm for each individual medium in the package. | 08-26-2010 |
Frank Levinson, Syracuse, IN US
| Patent application number | Description | Published |
|---|---|---|
| 20110311230 | OPTICAL BUS - An optical bus. Optical sub-assemblies are used to connect lengths of optical fiber to form a single optical fiber that is a bus. A master transceiver may be connected to one end of the fiber and nodes can be connected to the optical sub-assemblies. Each optical sub-assembly includes a center fiber with a mirror that enables each connector to reflect optical signals out of the fiber and that enables a node to launch optical signals on the optical bus. The optical bus can also be connected with a second transceiver that may be used to deliver optical power to the attached nodes. Some nodes include two optical subassemblies to enable bidirectional communication on the optical bus. | 12-22-2011 |
| 20110318000 | OPTICAL BUS - An optical bus. Optical sub-assemblies are used to connect lengths of optical fiber to form a single optical fiber that is a bus. A master transceiver may be connected to one end of the fiber and nodes can be connected to the optical sub-assemblies. Each optical sub-assembly includes a center fiber with a mirror that enables each connector to reflect optical signals out of the fiber and that enables a node to launch optical signals on the optical bus. The optical bus can also be connected with a second transceiver that may be used to deliver optical power to the attached nodes. Some nodes include two optical subassemblies to enable bidirectional communication on the optical bus. | 12-29-2011 |
Joshua A. Levinson, Zionsville, PA US
| Patent application number | Description | Published |
|---|---|---|
| 20120022296 | Method for the preparation of sevoflurane - A method for the preparation of (CF | 01-26-2012 |
Matthew Levinson, Lincolnwood, IL US
| Patent application number | Description | Published |
|---|---|---|
| 20090093394 | Fabric Conditioning Compositions - A fabric softening composition comprising from 1 to 80% by weight of ester-linked quaternary ammonium fabric softening material comprising a quaternised mixture of mono- di- and tri-ester of alkanolamine in which the tri-ester content of said mixture is from 25 to 50% by weight of said mixture, wherein: (i) when the tri-ester content is from 25 to 30% by weight of said mixture the free amine content of the composition is less than 0.5% by weight on the weight of said mixture, (ii) when the tri-ester content is more than 30% by weight of said mixture the free amine content of the composition is less than 6% by weight based on the weight of said mixture, the composition containing less than 1% by weight of free fatty acid based on said mixture. | 04-09-2009 |
Matthew I. Levinson, Chicago, IL US
| Patent application number | Description | Published |
|---|---|---|
| 20100197560 | Fabric Conditioning Active Compositions - A fabric conditioning active composition comprising an esterquat mixture of quaternised mono- di- and tri-esters of alkanolamine in which the tri-esterquat content of the quaternised esterquat mixture is from 25 to 50% by weight of said esterquat mixture. Additionally, (i) when the triesterquat content is from 25 to 30% by weight of said esterquat mixture the free amine content of the composition is less than 0.5% by weight on the weight on said esterquat mixture, and (ii) when the tri-esterquat content is more than 30% by weight of said esterquat mixture the free amine content of the composition is less than 6% by weight based on the weight of said esterquat mixture. The composition may contain less than 1% by weight of free fatty acid based on said esterquat mixture. | 08-05-2010 |
Melvin Leroy Levinson, Edison, NJ US
| Patent application number | Description | Published |
|---|---|---|
| 20090121798 | HIGH POWER MICROWAVE WASTE MANAGEMENT - A variable capacitor power supply for a high-power, industrial magnetron is powered directly from a conventional, public-service, 4,160 volt and higher power line. The magnetron's output is removably attached to a tractor trailers or train boxcar fabricated as a microwave work chambers. Microwave work chambers are configured to dry waste, burn dried waste, enhance chemical processes, fix free nitrogen, burn waste metal, reclaim component metals from mixed waste metal, and for gasification, pyrolysis, and plasma waste disposal. Alternately, the microwave power supply is removably connected to an underground cave, configured as a microwave oven chamber, to microwave waste therein. The microwave power supply is located in the basement of a high rise building designed to convert the high rise building waste into heat and electricity. | 05-14-2009 |
Michael J. Levinson, Midland, MI US
| Patent application number | Description | Published |
|---|---|---|
| 20090054861 | ADHESION PROMOTERS FOR MULTISTRUCTURAL LAMINATES - Compositions and methods for improving the adhesion of a film to a nonwoven, a film to another film, or a nonwoven to another nonwoven are disclosed. Depending on the laminate or multilaminate structure, the improvement can be achieved by using low viscosity, low density ethylene- or propylene-based polymers, which physically anchor to the substrate, such as a porous nonwoven, or by using a similar polymer in a blend with one of the substrate film polymers to improve flow and adhesion. | 02-26-2009 |
Rich Levinson, Concord, MA US
| Patent application number | Description | Published |
|---|---|---|
| 20110030041 | Session Ticket Authentication Scheme - A method of propagating a user's authentication/session information between different requests to Web services in a network includes a web server receiving a request for access to a first web service. The request is intercepted with an agent and authentication credentials are collected. A determination is made whether the web service customer is authenticated and authorized. If the web service customer is authenticated and authorized, a session and session ticket are created. An ID and the session ticket are returned to the web server. The session ticket ID and a public key are encrypted into an assertion. The assertion is sent to the first web service. The assertion is then returned to the web service customer for use with future requests. The assertion can be in the form of a SAML assertion. | 02-03-2011 |
Ronald Levinson, Tampa, FL US
| Patent application number | Description | Published |
|---|---|---|
| 20100114758 | SYSTEM AND METHOD FOR PROVIDING INSTANT-DECISION, FINANCIAL NETWORK-BASED PAYMENT CARDS - A system and method for issuance of a financial network-based payment card (generally known as a “credit card”) almost instantaneously after application, wherein an applicant applies for a credit card by entering data into a data entry system, advantageously by filling in a plurality of predefined forms in a computer-based data entry system. The applicant's data is sent via a data network to a central decision center, which approves or disapproves the application. If the application is approved, data is generated and delivered to a card production system, which embosses and magnetically encodes a card blank. The card is then delivered to the applicant. | 05-06-2010 |
| 20110288990 | SYSTEM AND METHOD FOR PROVIDING INSTANT-DECISION, FINANCIAL NETWORK-BASED PAYMENT CARDS - A system and method for issuance of a financial network-based payment card (generally known as a “payment card” or a “credit card”) almost instantaneously after application, wherein an applicant applies for a credit card by entering data into a data entry system using a handheld electronic device, advantageously by filling in a plurality of predefined forms in a computer-based data entry system. The applicant's data is sent via a data network to a central decision center, which approves or disapproves the application. If the application is approved, data is generated, a payment card is activated, and a result of the determination to issue is sent to the handheld electronic device | 11-24-2011 |
R. Saul Levinson, Chesterfield, MO US
| Patent application number | Description | Published |
|---|---|---|
| 20080299050 | TOPICAL THERAPIES FOR ORAL MUCOSITIS AND OTHER CONDITIONS - A method for treating oral mucositis in a subject comprises topically administering to an oral mucosal surface of the subject phenyloin or a pharmaceutically acceptable salt thereof in an amount effective to inhibit mucosal degeneration or promote mucosal regeneration, and optionally an analgesic agent in an amount effective, in combination with the phenyloin or salt thereof, to reduce pain associated with the oral mucositis. The phenyloin or salt thereof and optionally the analgesic agent can be administered in a pharmaceutical composition comprising an excipient vehicle suitable for intraoral administration, said composition being bioadhesive to an oral mucosal surface, for example having at least one non-lipoidal internal phase and at least one lipoidal external phase that is bioadhesive to said surface. | 12-04-2008 |
| 20090068289 | FORMULATION FOR MENOPAUSAL WOMEN - The present disclosure relates to novel compositions which provide improved nutritional support for premenopausal and menopausal women and/or relief from systems associated with menopause, as well as prophylactic effects, and methods for using same. | 03-12-2009 |
| 20090075963 | TRANSDERMAL HORMONE SPRAY - The present invention provides a transdermal spray drug delivery system which comprises: a therapeutically effective amount of a hormone; at least one dermal penetration enhancer; and at least one volatile liquid. The invention also provides a method for administering at least one systemic acting hormone which comprises applying an effective amount of the hormone in the form of the drug delivery system of the present invention. | 03-19-2009 |
| 20090270503 | NUTRITIONAL SUPPLEMENTS - The present disclosure relates to novel nutritional methods and compositions containing essential fatty acids which optimize embryonic, fetal and child neurological development and provides improved nutritional support for women prior to and during lactation. Further the methods and compositions improve gestational length and birth weight. The nutritional methods and compositions are also intended for use by women to optimize infant neurological development and provide improved nutritional support for women prior to, during and after lactation. | 10-29-2009 |
| 20100129496 | NUTRITIONAL FORMULATIONS - This invention relates to novel nutritional supplements comprising essential fatty acids and iron, as well as methods related thereto. | 05-27-2010 |
| 20110251141 | COMPOSITION FOR TOPICAL TREATMENT OF MIXED VAGINAL INFECTIONS - A pharmaceutical composition comprises (a) an antibacterial agent in an antibacterially effective amount, illustratively comprising clindamycin or a pharmaceutically acceptable salt or ester thereof; and (b) an antifungal agent in an antifungally effective amount, illustratively comprising butoconazole or a pharmaceutically acceptable salt or ester thereof. The composition is adapted for application in a unit dose amount to a vulvovaginal surface and has at least one nonlipoidal internal phase and at least one lipoidal external phase that is bioadhesive to the vulvovaginal surface. The composition is useful for administration to a vulvovaginal surface to treat a mixed bacterial vaginosis and vulvovaginal candidiasis infection. | 10-13-2011 |
| 20110276030 | DELIVERY SYSTEM - A pharmaceutical delivery system that releases an active agent in a controlled manner for an extended period in the vaginal cavity to treat or cure ailments associated with the vaginal cavity or proximal areas. The delivery system includes an applicator which is composed of a high internal phase emulsion, allowing the delivery system to adhere to the mueosal surfaces of the body, primarily the lining of vaginal cavity. The delivery system can maintain the high internal phase emulsion at a temperature of 86° F. for at least one month, without decomposition or instability of the emulsion. | 11-10-2011 |
Scott Levinson, Austin, TX US
| Patent application number | Description | Published |
|---|---|---|
| 20120046898 | SYSTEMS AND METHODS FOR PRESSURE MEASUREMENT USING OPTICAL SENSORS - Embodiments of systems and methods for pressure measurement using optical sensors are disclosed that include a computer processor that executes logic instructions to receive data based on optical signals from an optical sensor. The data represents velocity of the object after being exposed to a first pressure force. The velocity is determined from an unshifted, reference optical signal and a Doppler-shifted optical signal reflected off the object. The pressure force applied to the object is determined based on the velocity of the object. | 02-23-2012 |
Simon Rock Levinson, Denver, CO US
| Patent application number | Description | Published |
|---|---|---|
| 20090196902 | BIOGENERATOR CONSTRUCTED USING LIVE CELL CULTURES - An apparatus (or a biogenerator) is disclosed which utilizes the electrochemical polarization of epithelial cells to generate electricity. The apparatus employs living cells to convert chemical energy into electricity. The biogenerator is capable of supplying electricity to other devices continuously for extended periods of time. Because the apparatus may be made sufficiently small for implantation into the body of an animal or a human, such an apparatus is particularly useful for powering devices that require implantation into the host body. | 08-06-2009 |
Stephen Ronald Levinson, Easton, CT US
| Patent application number | Description | Published |
|---|---|---|
| 20100070304 | SYSTEM AND METHOD FOR RECOGNIZING MEDICATION SIDE EFFECTS IN PATIENTS - A system for automatically correlating a patient's symptom with medication side effects includes: a computing device for use by medical personnel to input and display data; a first database including an electronic health record (EHR) for the patient; a second database including Physician's Desk Reference (PDR) data regarding side effects of medications; and a server configured to receive information from the computing device regarding the symptom; retrieve a list of the patient's medications from the first database; obtain a record of recognized side effects of those medications from the second database; and transmit a message to the computing device regarding medications and side effects correlated with the symptom. | 03-18-2010 |